Tumor Radioactivity in 99mTc-GSA Scintigraphy Predicts Oncological Outcomes in Patients Who Underwent Hepatectomy for Hepatocellular Carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Technetium-99m-diethylenetriaminepentaacetic acid-galactosyl human serum albumin (99mTc-GSA) scintigraphy can predict hepatocellular carcinoma (HCC) survival. Low tumor radioactivity in 99mTc-GSA scans indicates a poor prognosis for disease-free and overall survival in HCC patients.
Area Of Science
- Hepatobiliary imaging
- Nuclear medicine
- Oncology
Background
- Technetium-99m-diethylenetriaminepentaacetic acid-galactosyl human serum albumin (99mTc-GSA) scintigraphy is a standard preoperative liver reserve test.
- Hepatocellular carcinoma (HCC) is a primary liver malignancy.
- Assessing tumor biology and patient prognosis is crucial in HCC management.
Purpose Of The Study
- To investigate the correlation between tumor radioactivity in 99mTc-GSA scintigraphy and patient survival in HCC.
- To determine the prognostic value of 99mTc-GSA tumor radioactivity for disease-free survival (DFS) and overall survival (OS).
Main Methods
- 115 patients with HCC undergoing hepatectomy were included.
- 99mTc-GSA scintigraphy was performed preoperatively.
- Tumor radioactivity was assessed and correlated with DFS and OS.
Main Results
- Hepatic uptake index correlated with liver fibrosis.
- High tumor radioactivity in 99mTc-GSA scans indicated high asialoglycoprotein receptor expression and was linked to tumor differentiation and size.
- Low tumor radioactivity independently predicted poor DFS and OS.
Conclusions
- 99mTc-GSA scintigraphy is valuable for preoperative hepatic function evaluation in HCC.
- Tumor radioactivity in 99mTc-GSA scans can assess aggressive tumor biology and predict HCC patient outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
